1. Sina B. Focus on Plasmodium vivax. Trends Parasitol. 2002. 18:287–289.
Article
2. Drouin J, Rock G, Jolly EE. Plasmodium falciparum malaria mimicking autoimmune hemolytic anemia during pregnancy. Can Med Assoc J. 1985. 132:265–267.
3. Dhaliwal G, Cornett PA, Tierney LM Jr. Hemolytic anemia. Am Fam Physician. 2004. 69:2599–2606.
4. Facer CA, Bray RS, Brown J. Direct Coombs antiglobulin reactions in Gambian children with Plasmodium falciparum malaria: I. Incidence and class specificity. Clin Exp Immunol. 1979. 35:119–127.
5. Galinski MR, Barnwell JW. Plasmodium vivax: Merozoites, invasion of reticulocytes and considerations for malaria vaccine development. Parasitol Today. 1996. 12:20–29.
Article
6. World Health Organization, Communicable Diseases Cluster. Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000. 94:1. S1–90.
7. Selvam R, Baskaran G. Hematological impairments in recurrent Plasmodium vivax infected patients. Jpn J Med Sci Biol. 1996. 49:151–165.
Article
8. Collins WE, Jeffery GM, Roberts JM. A retrospective examination of anemia during infection of humans with Plasmodium vivax. Am J Trop Med Hyg. 2003. 68:410–412.
Article
9. Song HH, O SO, Kim SH, Moon SH, Kim JB, Yoon JW, Koo JR, Hong KS, Lee MG, Kim DJ, Shin DH, Kang SH, Choi MG, Lee KH. Clinical features of Plasmodium vivax Malaria. Korean J Intern Med. 2003. 18:220–224.
Article
10. Maedel L, Sommer S. Morphologic changes in erythrocytes. 1993. Chicago: American Society for Clinical Pathology Press;4:Slides 50,52,66.
11. Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA. 1980. 243:1909–1911.
Article
12. Jefferies LC. Transfusion therapy in autoimmune hemolytic anemia. Hematol Oncol Clin North Am. 1994. 8:1087–1104.
Article
13. Berkowitz FE. Hemolysis and infection: categories and mechanisms of their interrelationship. Rev Infect Dis. 1991. 13:1151–1162.
Article